Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Abbisko Cayman Limited ( (HK:2256) ) has shared an announcement.
Abbisko Cayman Limited announced amendments to its Post-IPO RSU and Share Option Schemes, allowing the use of treasury shares to satisfy grants and exercises. This aligns with recent changes in the Listing Rules, providing the company with greater flexibility in managing these schemes and potentially enhancing its operational efficiency.
More about Abbisko Cayman Limited
Abbisko Cayman Limited is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. It focuses on developing and providing innovative therapeutic solutions, with a market focus on enhancing long-term growth and profitability through strategic initiatives like share schemes.
YTD Price Performance: 46.09%
Average Trading Volume: 5,887,410
Technical Sentiment Signal: Sell
Current Market Cap: HK$4.87B
Find detailed analytics on 2256 stock on TipRanks’ Stock Analysis page.